These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21871507)

  • 1. Nanoparticle delivery of a peptide targeting EGFR signaling.
    Kim SK; Huang L
    J Control Release; 2012 Jan; 157(2):279-86. PubMed ID: 21871507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles.
    Kim SK; Foote MB; Huang L
    Cancer Lett; 2013 Jul; 334(2):311-8. PubMed ID: 22796364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy.
    Chen Y; Wu JJ; Huang L
    Mol Ther; 2010 Apr; 18(4):828-34. PubMed ID: 20068551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Paclitaxel-loaded EGFR Peptide-conjugated Magnetic Polymeric Liposomes for Liver Cancer Therapy.
    Lin ZL; Ding J; Sun GP; Li D; He SS; Liang XF; Huang XR; Xie J
    Curr Med Sci; 2020 Feb; 40(1):145-154. PubMed ID: 32166677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.
    Chen Y; Sen J; Bathula SR; Yang Q; Fittipaldi R; Huang L
    Mol Pharm; 2009; 6(3):696-705. PubMed ID: 19267451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles.
    Kim SK; Foote MB; Huang L
    Biomaterials; 2012 May; 33(15):3959-66. PubMed ID: 22365810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferumoxytol and CpG oligodeoxynucleotide 2395 synergistically enhance antitumor activity of macrophages against NSCLC with EGFR
    Wang G; Zhao J; Zhang M; Wang Q; Chen B; Hou Y; Lu K
    Int J Nanomedicine; 2019; 14():4503-4515. PubMed ID: 31417255
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer.
    Liu H; Lu J; Hua Y; Zhang P; Liang Z; Ruan L; Lian C; Shi H; Chen K; Tu Z
    Cell Death Dis; 2015 Jan; 6(1):e1595. PubMed ID: 25590805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer.
    Milane L; Duan Z; Amiji M
    PLoS One; 2011; 6(9):e24075. PubMed ID: 21931642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential peptide therapeutic derived from the juxtamembrane domain of the epidermal growth factor receptor.
    Boran AD; Seco J; Jayaraman V; Jayaraman G; Zhao S; Reddy S; Chen Y; Iyengar R
    PLoS One; 2012; 7(11):e49702. PubMed ID: 23166750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis.
    Liu WJ; Liu XJ; Xu J; Li L; Li Y; Zhang SH; Wang JL; Miao QF; Zhen YS
    Acta Pharmacol Sin; 2018 Nov; 39(11):1777-1786. PubMed ID: 30013033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2.
    Chen Y; Wu J; Yan H; Cheng Y; Wang Y; Yang Y; Deng M; Che X; Hou K; Qu X; Zou D; Liu Y; Zhang Y; Hu X
    Pharmacol Res; 2020 Sep; 159():105007. PubMed ID: 32561477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer.
    Liao Y; Guo Z; Xia X; Liu Y; Huang C; Jiang L; Wang X; Liu J; Huang H
    J Exp Clin Cancer Res; 2019 Apr; 38(1):157. PubMed ID: 30975171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression.
    Li W; Liu Z; Li C; Li N; Fang L; Chang J; Tan J
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):619-32. PubMed ID: 26573511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
    Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo.
    Zhong Y; Wang C; Cheng R; Cheng L; Meng F; Liu Z; Zhong Z
    J Control Release; 2014 Dec; 195():63-71. PubMed ID: 25108151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy.
    Jin H; Pi J; Zhao Y; Jiang J; Li T; Zeng X; Yang P; Evans CE; Cai J
    Nanoscale; 2017 Nov; 9(42):16365-16374. PubMed ID: 29052674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor.
    Chono S; Li SD; Conwell CC; Huang L
    J Control Release; 2008 Oct; 131(1):64-9. PubMed ID: 18674578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.